ImmuCell CorporationICCCNASDAQ
Loading
Year-over-year revenue growth rate
| Period | Value |
|---|---|
| Q4 2025 | 38.50% |
| Q3 2025 | -14.57% |
| Q2 2025 | -20.11% |
| Q1 2025 | 4.08% |
| Q4 2024 | 28.94% |
| Q3 2024 | 9.84% |
| Q2 2024 | -24.59% |
| Q1 2024 | 42.42% |
| Q4 2023 | -5.57% |
| Q3 2023 | 52.76% |
| Q2 2023 | 2.50% |
| Q1 2023 | -11.87% |
| Q4 2022 | -18.46% |
| Q3 2022 | 24.21% |
| Q2 2022 | -35.64% |
| Q1 2022 | 10.21% |
| Q4 2021 | 5.70% |
| Q3 2021 | 13.39% |
| Q2 2021 | 10.58% |
| Q1 2021 | 9.73% |
| Q4 2020 | 0.55% |
| Q3 2020 | 25.51% |
| Q2 2020 | -39.60% |
| Q1 2020 | 35.20% |
| Q4 2019 | 22.27% |
| Q3 2019 | 9.61% |
| Q2 2019 | -38.56% |
| Q1 2019 | 50.17% |
| Q4 2018 | 36.37% |
| Q3 2018 | -28.55% |
| Q2 2018 | 4.63% |
| Q1 2018 | -8.04% |
| Q4 2017 | 56.26% |
| Q3 2017 | 14.60% |
| Q2 2017 | -50.63% |
| Q1 2017 | 60.08% |
| Q4 2016 | 12.48% |
| Q3 2016 | -17.15% |
| Q2 2016 | -20.45% |
| Q1 2016 | 10.84% |